Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM
NCT04653246
Age 75 +
Sex Both
Phase Phase 2
Third Opinion Trial Synopsis
This study is checking if a new medicine called isatuximab is safe and works well for people with a cancer called multiple myeloma. It will be given with other medicines that are commonly used for this type of cancer.
This study is checking if a new medicine called isatuximab is safe and works well for people with a cancer called multiple myeloma. It will be given with other medicines that are commonly used for this type of cancer.
Third Opinion AI Generated Synopsis
Trial Summary
This research is testing whether the investigational drug isatuximab is safe and effective when used in combination with standard agents for the treatment of newly diagnosed multiple myeloma.
This research is testing whether the investigational drug isatuximab is safe and effective when used in combination with standard agents for the treatment of newly diagnosed multiple myeloma.
from ClinicalTrials.gov
Locations & Contact
Fill out the form and to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts:
